Orchid Chemicals and Pharmaceutical has plunged 10% to Rs 171 on reporting a consolidated net loss of Rs 11.06 crore for the third quarter ended December 2011, compared with a net profit of Rs 56.62 crore in a year earlier. The performance in the recently concluded quarter was impacted by to higher interest charges and the exchange loss on outstanding foreign currency loans. Revenues grew by 4% at Rs 497 crore on year-on-year basis.

EBITDA (earnings before interest tax and depreciation) declined at Rs 129 crore in Q3 FY12 against Rs 131 crore in the corresponding quarter of last fiscal, the pharmaceutical company said in a filing to the stock exchanges.

As many as 7.08 million shares have already changed hands on the counter till noon deals, as against an average around 2.2 million shares that were traded daily in past ten trading days on the NSE and BSE.